X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CNS Neuroscience & Therapeutics

期刊標題檢索 CNS NEUROSCI TH 最新評論: Submitted October 4, 2023 Final revisions submitted December 15, 20... (2024-04-02)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CNS Neuroscience & Therapeutics]您好,您是該頁面的第 109920 位訪客。

期刊簡介
期刊名稱CNS Neuroscience & Therapeutics CNS Neuroscience & Therapeutics
LetPub Score
7.4
50 ratings
Rate

Reputation
8.4

Influence
6.3

Speed
9.2

期刊簡稱CNS NEUROSCI THER
ISSN1755-5930
E-ISSN1755-5949
h-index59
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.301.4731.207
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q148 / 272
Category: Medicine
Subcategory: Psychiatry and Mental Health
Q1104 / 567
Category: Medicine
Subcategory: Physiology (medical)
Q127 / 113
Category: Medicine
Subcategory: Pharmacology
Q284 / 313

自引率 (2023-2024)4.20%自引率趨勢
掲載範囲
CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.
官方網站https://onlinelibrary.wiley.com/journal/17555949
在線稿件提交http://mc.manuscriptcentral.com/cnsdr
開放訪問Yes
出版商Wiley-Blackwell Publishing Ltd
主題領域医学
出版國/地區ENGLAND
發行頻率四半期刊行
創刊年2008
每年文章數443每年文章數趨勢
黃金OA百分比77.78%
OA Related Info
APC: Yes( USD3410; GBP2590; EUR2920; )
APC waiver:Check Notes
Other charges: No
Keywords: neuroscience、neurology、central nervous system、pharmacology、degenerative diseases、pharmacokinetics
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
NEUROSCIENCESSCIEQ157/310
PHARMACOLOGY & PHARMACYSCIEQ150/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1755-5930%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 75%
參考鏈接
相關期刊 【CNS Neuroscience & Therapeutics】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS NEUROSCIENCEH-index: 357

    CiteScore: 35.00
    NATURE NEUROSCIENCEH-index: 375

    CiteScore: 38.60
    Molecular NeurodegenerationH-index: 66

    CiteScore: 23.00
    NeuronH-index: 430

    CiteScore: 24.50
    TRENDS IN NEUROSCIENCESH-index: 269

    CiteScore: 26.50
    Annual Review of NeuroscienceH-index: 224

    CiteScore: 25.30
    Journal of NeuroinflammationH-index: 92

    CiteScore: 15.90
    PROGRESS IN NEUROBIOLOGYH-index: 212

    CiteScore: 12.80
    NeurotherapeuticsH-index: 100

    CiteScore: 11.00
    GLIAH-index: 148

    CiteScore: 13.10
    學科內最受檢索的期刊 頁面查看次數
    JOURNAL OF NEUROSCIENCE185707
    NEUROSCIENCE168124
    BRAIN RESEARCH139944
    Journal of Neuroinflammation131832
    MOLECULAR NEUROBIOLOGY128495
    Neuron121471
    NEUROSCIENCE LETTERS114985
    NATURE NEUROSCIENCE98224
    CEREBRAL CORTEX97889
    NEUROPHARMACOLOGY94352
  •  

    CNS Neuroscience & Therapeutics CNS Neuroscience & Therapeutics
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CNS Neuroscience & Therapeutics] 的評論撰寫評論
作者: TerryHo


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-04-02 22:57:35 評論於
Submitted
October 4, 2023
Final revisions submitted
December 15, 2023
Accepted
March 25, 2024
(0) 讚! | TerryHo

作者: xwh123


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2023-06-03 09:31:57 評論於
Really rubbish, reviewed for a month, thought it was being reviewed, but it turns out it's still being edited over there, and they even said it would be quickly rejected...
(1) 讚! | xwh123

作者: heyingkun


領域: 医学
審稿時間: 8.0 month(s)
結果: 修改後接受


撰寫評論

2023-03-05 12:19:40 評論於
Submitted
October 27, 2022

Final revisions submitted
January 27, 2023

Accepted
February 14, 2023

Version of Record online
February 27, 2023

Article made open access
February 27, 2023
(2) 讚! | heyingkun

作者: 芒硝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-26 09:53:07 評論於
Hello, may I ask if you will be submitting again in the old system? I also submitted my manuscript from the new system. I checked the "Author's Note" in the old system, which stated that if you submitted from the new system, you need to exit "ScholarOne Manuscripts" and return to the "Research Exchange" system. So, I'm not sure if I need to submit again.
(0) 讚! | 芒硝

作者: zenithcloud


領域: 医学
審稿時間: 5.0 month(s)
結果: 拒稿


撰寫評論

2023-01-25 10:50:26 評論於
Not recommended at all, a trash magazine. It took 5 months for them to review the submission, and they only assigned one reviewer. The review comments were also very unprofessional.
(0) 讚! | zenithcloud

作者: hengzhang


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-10 23:33:08 評論於
I tell you, if you go into the old system again, you will find a column called "Author". On the left side, there is a section called "Submitted Manuscripts" where you can find the manuscripts you have submitted. Follow the steps there to submit and you will receive a manuscript number and an email.
(0) 讚! | hengzhang

作者: 我爱开心


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-08 21:53:16 評論於
It has been 2 days since I submitted with the new system, but it still shows "submitted" and I haven't received the Manuscript ID. Is this normal?
(0) 讚! | 我爱开心

作者: 火星人科学家


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2019-08-21 09:53:40 評論於
It was stated on the submission site that "First review returned 7 working days from online submission". It was rejected in a week after submission and it doesn’t waste the time.

(0) 讚! | 火星人科学家

作者: promoter


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2017-05-17 18:06:44 評論於
I don’t know what the IF will be this year, I hope to keep it at 4 points or more
(0) 讚! | promoter

作者: xxyuluo@126.com


領域: 生命科学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2015-11-24 14:52:40 評論於
Review speed at this journal is very efficient. After submitting the manuscript, I received the confirmation email from the AE almost immediately. The review was finished within 3 weeks and I revised and resubmitted my article within 4 weeks. I appreciate the journal’s highly efficient work attitude. In addition, the review does not charge, but official publication requires a $1000 US dollars page fee.

(0) 讚! | xxyuluo@126.com

作者: Anonymous


領域: 生命科学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2015-04-27 11:04:50 評論於
journal has risen, and the quality of the article is much higher than before.After all, it is a journal that Chinese people take over. I hope that the journal will be better and better, and at the same time strictly control the quality of the article and produce international-level journals.Don't sacrifice the quality of the article for the cost of the page.
(0) 讚! | Anonymous

作者: eagle


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2014-11-18 18:07:07 評論於
Is it a few districts under the Chinese Academy of Sciences?
(1) 讚! | eagle

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-06-21 14:02:00 評論於
was edited by Su Dingfeng, professor of pharmacology at the Second Military Medical University. The deputy editors are Wang Yongjun and Hu Gang.
(2) 讚! | 匿名

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CNS Neuroscience & Therapeutics] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*